The incidence of pancreatic carcinoma has increased during recent decades, and it is the fourth most common cause of cancer-related mortality [ 1 x [1] Eskelinen, M.J. and Haglund, U.H. Prognosis of human pancreatic adenocarcinoma: review of clinical and histopathological variables and possible uses of new molecular methods. Eur J Surg. 1999; 165: 292–306 Crossref | PubMed | Scopus (41) | Google Scholar See all References , 2 x [2] Silverman, D.T., Schiffman, M., Everhart, J., Goldstein, A., Lillemoe, K.D., and Swanson, G.M. Diabetes mellitus, other medical conditions and familial history of cancer as risk factors for pancreatic cancer. Br J Cancer. 1999; 80: 1830–1837 Crossref | PubMed | Scopus (314) | Google Scholar See all References ]. Early systemic dissemination and local cancer progression are limitations of curative treatment [ 3 x [3] DiMagno, E.P., Reber, H.A., and Tempero, M.A. AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology. 1999; 117: 1464–1484 Abstract | Full Text | Full Text PDF | PubMed | Scopus (320) | Google Scholar See all References ] [3] . Overall cumulative 5-year survival is extremely poor (0.4–1%), and after curative resection is only 5–15%[ 4 x [4] Bramhall, S.R., Allum, W.H., Jones, A.G., Allwood, A., Cummins, C., and Neoptolemos, J.P. Treatment and survival in 13,560 patients with pancreatic cancer, and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg. 1995; 82: 111–115 Crossref | PubMed | Scopus (449) | Google Scholar See all References , 5 x [5] Neoptolemos, J.P., Dunn, J.A., Stocken, D.D., Almond, J., Link, K., and Beger, H. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet. 2001; 358: 1576–1585 Abstract | Full Text | Full Text PDF | PubMed | Scopus (681) | Google Scholar See all References , 6 x [6] Yeo, C.J., Sohn, T.A., Cameron, J.L., Hruban, R.H., Lillemoe, K.D., and Pitt, H.A. Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg. 1998; 227: 821–831 Crossref | PubMed | Scopus (331) | Google Scholar See all References , 7 x [7] Carr, J.A., Ajlouni, M., Wollner, I., Wong, D., and Velanovich, V. Adenocarcinoma of the head of the pancreas: effects of surgical and nonsurgical therapy on survival – a ten-year experience. Am Surg. 1999; 65: 1143–1149 PubMed | Google Scholar See all References ]. Pathological stage, histological differentiation, localization of the tumour and involved margins are known prognostic factors [ 8 x [8] Geer, R.J. and Brennan, M.F. Prognostic indicators for survival after resection of pancreatic adenocarcinoma. Am J Surg. 1993; 165: 68–72 Abstract | Full Text PDF | PubMed | Scopus (682) | Google Scholar See all References , 9 x [9] Fortner, J.G., Klimstra, D.S., Senie, R.T., and Maclean, B.J. Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy. Ann Surg. 1996; 223: 147–153 Crossref | PubMed | Scopus (213) | Google Scholar See all References , 10 x [10] Magistrelli, P., Antinori, A., Crucitti, A., La Greca, A., Masetti, R., and Coppola, R. Prognostic factors after surgical resection for pancreatic carcinoma. J Surg Oncol. 2000; 74: 36–40 Crossref | PubMed | Scopus (65) | Google Scholar See all References , 11 x [11] Lundin, J., Nordling, S., von Boguslawsky, K., Roberts, P.J., and Haglund, C. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer. Anticancer Res. 1995; 15: 2659–2668 PubMed | Google Scholar See all References , 12 x [12] Luttges, J., Schemm, S., Vogel, I., Hedderich, J., Kremer, B., and Kloppel, G. The grade of pancreatic ductal carcinoma is an independent prognostic factor and is superior to the immunohistochemical assessment of proliferation. J Pathol. 2000; 191: 154–161 Crossref | PubMed | Scopus (103) | Google Scholar See all References , 13 x [13] Takahashi, T., Niino, N., Ishikura, H., Okushiba, S., Dohke, M., and Katoh, H. Predictive factors for long-term survival in patients with pancreatic carcinoma. Hepatogastroenterology. 1997; 44: 1463–1468 PubMed | Google Scholar See all References ].